{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:40:02Z","timestamp":1756284002443,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,16]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Neurological complications of SARS-CoV-2 continue to be recognised. In children, neurological phenomenon has been reported generally in the acute infectious period. It is possible that SARS-CoV-2 could trigger an immune-mediated post-infectious phenomenon. Here, we present a unique case of post-infectious marantic cardiac lesion causing cerebrovascular accident in a patient with Down syndrome.<\/jats:p>","DOI":"10.1136\/bcr-2020-240490","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T12:44:28Z","timestamp":1618490668000},"page":"e240490","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Post-infectious inflammatory syndrome associated with SARS-CoV-2 in a paediatric patient with Down syndrome"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-8341","authenticated-orcid":false,"given":"Mellad","family":"Khoshnood","sequence":"first","affiliation":[{"name":"Division of Neurology, Children's Hospital Los Angeles, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Mahabir","sequence":"additional","affiliation":[{"name":"Department of Pathology, Keck School of Medicine at the University of Southern California, Los Angeles, California, USA"},{"name":"Department of Pathology, Children's Hospital Los Angeles, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick M","family":"Shillingford","sequence":"additional","affiliation":[{"name":"Department of Pathology, Keck School of Medicine at the University of Southern California, Los Angeles, California, USA"},{"name":"Department of Pathology, Children's Hospital Los Angeles, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D","family":"Santoro","sequence":"additional","affiliation":[{"name":"Division of Neurology, Children's Hospital Los Angeles, Los Angeles, California, USA"},{"name":"Department of Pediatrics, Children's Hospital of Los Angeles, Los Angeles, California, USA"},{"name":"Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"2025082700591672000_14.4.e240490.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04335.x"},{"key":"2025082700591672000_14.4.e240490.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03890.x"},{"key":"2025082700591672000_14.4.e240490.3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2020.06.076","article-title":"SARS-CoV-2 infection in patients with Down syndrome, congenital heart disease, and pulmonary hypertension: is Down syndrome a risk factor?","volume":"225","author":"Krishnan","year":"2020","journal-title":"J Pediatr"},{"key":"2025082700591672000_14.4.e240490.4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.003","article-title":"Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A\u00a0Systematic Review","volume":"226","author":"Abrams","year":"2020","journal-title":"J Pediatr"},{"key":"2025082700591672000_14.4.e240490.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941"},{"key":"2025082700591672000_14.4.e240490.6","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00415-020-09885-2","article-title":"Stroke in patients with SARS-CoV-2 infection: case series","volume":"267","author":"Morassi","year":"2020","journal-title":"J Neurol"},{"key":"2025082700591672000_14.4.e240490.7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MOP.0000000000000661","article-title":"Cardiovascular disease in Down syndrome","volume":"30","author":"Versacci","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"2025082700591672000_14.4.e240490.8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21060"},{"key":"2025082700591672000_14.4.e240490.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2010.05.007"},{"key":"2025082700591672000_14.4.e240490.10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/eji.201445049","article-title":"Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome","volume":"45","author":"Carsetti","year":"2015","journal-title":"Eur J Immunol"},{"key":"2025082700591672000_14.4.e240490.11","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-008-8113-y"},{"key":"2025082700591672000_14.4.e240490.12","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.046219"},{"key":"2025082700591672000_14.4.e240490.13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000362450","article-title":"Ten-Year longitudinal study of thyroid function in children with Down's syndrome","volume":"82","author":"Iughetti","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"2025082700591672000_14.4.e240490.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-015-0197-4","article-title":"Metamorphic thyroid autoimmunity in Down syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond","volume":"41","author":"Aversa","year":"2015","journal-title":"Ital J Pediatr"},{"key":"2025082700591672000_14.4.e240490.15","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J"},{"key":"2025082700591672000_14.4.e240490.16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.2.272"},{"key":"2025082700591672000_14.4.e240490.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198043","article-title":"Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China","volume":"286","author":"Li","year":"2020","journal-title":"Virus Res"},{"key":"2025082700591672000_14.4.e240490.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05991-x"},{"key":"2025082700591672000_14.4.e240490.19","doi-asserted-by":"crossref","first-page":"139021","DOI":"10.1016\/j.scitotenv.2020.139021","article-title":"Follow-up studies in COVID-19 recovered patients - is it mandatory?","volume":"729","author":"Balachandar","year":"2020","journal-title":"Sci Total Environ"},{"key":"2025082700591672000_14.4.e240490.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102315","article-title":"Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia","volume":"44","author":"Conte","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2025082700591672000_14.4.e240490.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102414","article-title":"Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod","volume":"45","author":"Mallucci","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2025082700591672000_14.4.e240490.22","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review","volume":"194","author":"Montalvan","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"2025082700591672000_14.4.e240490.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102469","article-title":"Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets","volume":"46","author":"Jack","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:59:27Z","timestamp":1756281567000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,15]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-240490"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240490","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}